Loading…

Loading grant details…

Active NON-SBIR/STTR RPGS NIH (US)

Chemical approaches for targeting ribonucleoprotein assemblies

$4.63M USD

Funder NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES
Recipient Organization St. Jude Children'S Research Hospital
Country United States
Start Date Sep 10, 2024
End Date Jul 31, 2029
Duration 1,785 days
Number of Grantees 1
Roles Principal Investigator
Data Source NIH (US)
Grant ID 10941909
Grant Description

PROJECT SUMMARY RNA-protein interactions play a fundamental role in biology through complex processes regulating gene expression programs. Perturbation of native RNA-protein assemblies (RNP) alters gene expression and can result in diseases, from infection to cancer to neurodegeneration. This proposal focuses on the discovery of chemical modulators of

RNA-protein assemblies through the systematic targeting of DEAD-box RNA-dependent ATPases. DEAD-box ATPases are the driving force of many RNP remodeling processes, including the functioning of RNA polymerase II, the spliceosome, the ribosome, and biomolecular RNA condensates. Unsurprisingly, mutations in DEAD-box

genes are implicated in cancer, neurodegenerative diseases, and rare genetic diseases. Despite their biological importance, our understanding of the remodeling activities and functions remains rudimentary for most of the 37 DEAD-box proteins in the human genome. We propose that developing selective chemical modulators of DEAD-

box proteins will propel biological studies of known and yet-to-be-discovered RNP and may lead to new drugs. As DEAD-box ATPases allosterically regulate RNA affinity through distal communication with the catalytic site, we hypothesize that we can generate selective inhibitors exploiting these allosteric mechanisms. We will provide proof-

of-concept for this approach through three projects: 1. Identify allosteric compounds that act as glues of DEAD-box proteins in complex with RNA by screening the large St. Jude compound collection. 2. Optimize stabilizers of RNA- helicase interaction for cell-based activity. We will combine ligand discovery with genetic-based approaches to

generate a chemical probe for studying DDX19 function in Ewing sarcoma. 3. Systematic discovery of targetable allosteric circuits in DEAD-box ATPases. We have identified ligands that bind DDX19 together with the nucleotide

cofactor. We will extend this approach to five structurally similar, but biologically and mechanistically distinct, DEAD- box ATPases. Using protein NMR and structural analyses, we will identify chemically targetable allosteric circuits and analyze their functional roles across the DEAD-box protein family. This multidisciplinary program will combine

structure-based design (synthetic chemistry and X-ray crystallography), protein dynamics (NMR), computational methods, biochemistry, and cell biology to determine how chemical modulators of RNA-protein assemblies can be generated. Successful completion of these projects will break new ground and could yield first-in-class chemical

probes for fundamental biological processes, providing approaches that are broadly applicable to nucleic acid- dependent ATPases and extendable to other protein-RNA interactions.

All Grantees

St. Jude Children'S Research Hospital

Advertisement
Apply for grants with GrantFunds
Advertisement
Browse Grants on GrantFunds
Interested in applying for this grant?

Complete our application form to express your interest and we'll guide you through the process.

Apply for This Grant